{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:50:40Z","timestamp":1787028640939,"version":"build-2736575974"},"reference-count":26,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Overactive bladder (OAB) is a syndrome defined as urinary urgency, accompanied by increased frequency and nocturia with or without urge incontinence, in the absence of urinary tract infection or other obvious pathology. The standard therapies are anticholinergic agents, selective beta-3 adrenoreceptor agonists, or intradetrusor injections of botulinum toxin (BTX-A). For patients with contraindications for BTX-A or drug therapies, percutaneous tibial nerve stimulation (PTNS) may be used. PTNS shows fewer side effects than anticholinergic drugs and costs less than BTX-A. The primary outcome of this study was to assess the efficacy of PTNS in women with refractory OAB. Methods: Women with refractory OAB undergoing PTNS at our tertiary referral center from 2017 to 2019 were included. The validated German Female Pelvic Floor Questionnaire and a micturition protocol were filled out before and after PTNS. PTNS was applied weekly for 12 weeks. Results: Improvements in OAB symptoms were seen in daily micturition frequency, urgency, and urgency incontinence from pre- to post-PTNS (p &lt; 0.006). Impairments to quality of daily life were significantly (p &lt; 0.0002) less severe after PTNS. There was a significant reduction in daytime voiding frequency from a median of nine to five (p &lt; 0.0001). Conclusions: Substantial reductions in OAB symptoms, daily micturition frequency, urgency, and urgency incontinence were found in patients with refractory OAB after PTNS.<\/jats:p>","DOI":"10.3390\/jcm12216783","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:50:18Z","timestamp":1698407418000},"page":"6783","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Percutaneous Tibial Nerve Stimulation in the Treatment of Refractory Idiopathic Overactive Bladder Syndrome: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"12","author":[{"given":"Janine Nicole","family":"Frey","sequence":"first","affiliation":[{"name":"Luzerner Kantonsspital Frauenklinik, Spitalstrasse, 6000 Luzern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3229-6200","authenticated-orcid":false,"given":"Angela","family":"Vidal","sequence":"additional","affiliation":[{"name":"Luzerner Kantonsspital Frauenklinik, Spitalstrasse, 6000 Luzern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Krebs","sequence":"additional","affiliation":[{"name":"Clinical Trial Unit, Swiss Paraplegic Centre, 6207 Nottwil, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Christmann","sequence":"additional","affiliation":[{"name":"Luzerner Kantonsspital Frauenklinik, Spitalstrasse, 6000 Luzern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol. Urodyn."},{"key":"ref_2","first-page":"2700227","article-title":"Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines","volume":"16","author":"Safi","year":"2022","journal-title":"Park. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.21037\/apm-21-339","article-title":"Effectiveness and safety of tibial nerve stimulation versus anticholinergic drugs for the treatment of overactive bladder syndrome: A meta-analysis","volume":"10","author":"Xiong","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_4","first-page":"484","article-title":"Overactive bladder-definition, epidemiology, pathogenesis","volume":"78","author":"Nowara","year":"2007","journal-title":"Ginekol. Pol."},{"key":"ref_5","first-page":"145","article-title":"Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome","volume":"9","author":"Heesakkers","year":"2017","journal-title":"Res. Rep. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.aju.2013.04.007","article-title":"Posterior tibial nerve stimulation as treatment for the overactive bladder","volume":"11","author":"Hammouda","year":"2013","journal-title":"Arab. J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40266-019-00674-9","article-title":"Relative Risk of Adverse Events and Treatment Discontinuations Between Older and Non-Older Adults Treated with Antimuscarinics for Overactive Bladder: A Systematic Review and Meta-Analysis","volume":"36","author":"Usmani","year":"2019","journal-title":"Drugs Aging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e12824","DOI":"10.1111\/ijcp.12824","article-title":"Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: A real-world claims data analysis","volume":"71","author":"Sussman","year":"2017","journal-title":"Int. J. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ogc.2015.10.002","article-title":"Overactive Bladder","volume":"43","author":"White","year":"2016","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_10","first-page":"8838","article-title":"Management of refractory idiopathic overactive bladder: Intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation","volume":"24","author":"Sherif","year":"2017","journal-title":"Can. J. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12325-019-01205-z","article-title":"New Technologies and Applications in Sacral Neuromodulation: An Update","volume":"37","author":"Knowles","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.surg.2016.10.038","article-title":"Fecal incontinence treated by sacral neuromodulation: Long-term follow-up of 325 patients","volume":"161","author":"Janssen","year":"2017","journal-title":"Surgery"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1464-410x.2001.02219.x","article-title":"Neuromodulation techniques in the treatment of the overactive bladder","volume":"87","author":"Groen","year":"2001","journal-title":"BJU Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/nau.24038","article-title":"Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy","volume":"38","author":"Pincus","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1067\/mob.2002.125704","article-title":"The standardization of terminology of lower urinary tract function. Sub-committee of the International Continence Society","volume":"187","author":"Abrams","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000301098","article-title":"Validation of a Comprehensive Pelvic Floor Questionnarie for the Hospital, Private Practice and Research","volume":"49","author":"Baessler","year":"2009","journal-title":"Gyn\u00e4kol Geburtshofliche Rundsch."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00192-019-04186-3","article-title":"Posterior tibial nerve stimulation for overactive bladder-techniques and efficacy","volume":"31","author":"Bhide","year":"2020","journal-title":"Int. Urogynecol. J."},{"key":"ref_18","first-page":"513","article-title":"The impact of urodynamics on treatment and outcomes in women with an overactive bladder: A longitudinal prospective follow-up study","volume":"29","author":"Verghese","year":"2018","journal-title":"Int. Urogynecol. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s00192-020-04429-8","article-title":"Percutaneous tibial nerve stimulation for overactive bladder syndrome: A systematic review and meta-analysis","volume":"31","author":"Wang","year":"2020","journal-title":"Int. Urogynecol. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00192-018-3822-0","article-title":"Subjective and objective responses to PTNS and predictors for success: A retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder","volume":"30","author":"Iyer","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s11255-021-02999-0","article-title":"Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: Outcomes following a shortened 6-week protocol, a prospective randomized controlled trial","volume":"53","author":"Lashin","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.juro.2009.08.160","article-title":"Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder","volume":"183","author":"MacDiarmid","year":"2010","journal-title":"J. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.juro.2012.11.175","article-title":"Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study","volume":"189","author":"Peters","year":"2013","journal-title":"J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.23843","article-title":"Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial","volume":"38","author":"Kauffmann","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.physio.2018.12.002","article-title":"Single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in overactive bladder symptoms in women responders To Percutaneous Tibial Nerve Stimulation (PTNS)","volume":"105","author":"Crampton","year":"2019","journal-title":"Physiotherapy"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Agost-Gonz\u00e1lez, A., Escobio-Prieto, I., Pareja-Leal, A.M., Casuso-Holgado, M.J., Blanco-Diaz, M., and Albornoz-Cabello, M. (2021). Percutaneous versus Transcutaneous Electrical Stimulation of the Posterior Tibial Nerve in Idiopathic Overactive Bladder Syndrome with Urinary Incontinence in Adults: A Systematic Review. Healthcare, 9.","DOI":"10.3390\/healthcare9070879"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/21\/6783\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:12:25Z","timestamp":1760130745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/21\/6783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":26,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["jcm12216783"],"URL":"https:\/\/doi.org\/10.3390\/jcm12216783","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}